341 related articles for article (PubMed ID: 19031626)
1. [Management of mineral and bone disease caused by chronic renal disease: what recommendations have contributed].
Houillier P;
Nephrol Ther; 2008 Sep; 4 Spec No 1():2-8, 15-9. PubMed ID: 19031626
[No Abstract] [Full Text] [Related]
2. [KDIGO guidelines for the diagnosis and treatment of chronic kidney disease mineral and bone disorder: what's new?].
Limardo M; Pontoriero G; Locatelli F
G Ital Nefrol; 2010; 27(3):211-4. PubMed ID: 20540007
[No Abstract] [Full Text] [Related]
3. [SEN Guidelines. Recommendations of the Spanish Society of Nephrology for managing bone-mineral metabolic alterations in chronic renal disease patients].
Torregrosa JV; Cannata Andia J; Bover J; Caravaca F; Lorenzo V; Martín de Francisco AL; Martín-Malo A; Martínez I; González Parra E; Fernández Giráldez E; Rodríguez Portillo M;
Nefrologia; 2008; 28 Suppl 1():1-22. PubMed ID: 18338978
[No Abstract] [Full Text] [Related]
4. [Contributions of the software La Clé Concerto in the implementation of the NKF-K/DOQI (National Kidney Foundation-Kidney/Dialysis Outcomes Quality Initiative) recommendations for the control of mineral and bone metabolism disorders in the patient with chronic renal failure].
Ureña P
Nephrol Ther; 2008 Sep; 4 Spec No 1():9-14, 20-35. PubMed ID: 19031633
[No Abstract] [Full Text] [Related]
5. Mineral and bone disorder and outcomes in hemodialysis patients: results from the DOPPS.
Tentori F
Semin Dial; 2010; 23(1):10-4. PubMed ID: 20331811
[No Abstract] [Full Text] [Related]
6. The beehive and the merry-go-round in mineral metabolism.
Wolf M; Bushinsky DA
Curr Opin Nephrol Hypertens; 2011 Jul; 20(4):329-30. PubMed ID: 21654389
[No Abstract] [Full Text] [Related]
7. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview.
Bailie GR; Massry SG;
Pharmacotherapy; 2005 Dec; 25(12):1687-707. PubMed ID: 16305288
[TBL] [Abstract][Full Text] [Related]
8. [K/DOQI clinical practice guidelines for bone metabolism and disease in CKD].
Sakaguchi T; Akizawa T
Clin Calcium; 2004 Sep; 14(9):9-14. PubMed ID: 15577103
[TBL] [Abstract][Full Text] [Related]
9. [Changes in bone and mineral metabolism in kidney transplant patients with chronic kidney disease].
López Oliva MO; Del Castillo Caba D; Sánchez Plumed J
Nefrologia; 2009; 29 Suppl 1():31-7. PubMed ID: 19675659
[TBL] [Abstract][Full Text] [Related]
10. [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
Orita H; Akizawa T
Clin Calcium; 2004 May; 14(5):693-7. PubMed ID: 15577029
[TBL] [Abstract][Full Text] [Related]
11. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Introduction.
Torregrosa JV; Bover J; Cannata Andía J
Nefrologia; 2011; 31 Suppl 1():1-2. PubMed ID: 21468160
[No Abstract] [Full Text] [Related]
12. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults.
Bellorin-Font E; Ambrosoni P; Carlini RG; Carvalho AB; Correa-Rotter R; Cueto-Manzano A; Jara A; Jorgetti V; Negri AL; Olaizola I; Salusky I; Slatopolsky E; Weisinger JR; ;
Nefrologia; 2013; 33 Suppl 1():1-28. PubMed ID: 23629678
[TBL] [Abstract][Full Text] [Related]
13. [Chronic kidney disease (CKD) and bone. Chronic kidney disease--mineral and bone disorder in predialysis patients].
Inaguma D; Tatematsu M
Clin Calcium; 2009 Apr; 19(4):493-9. PubMed ID: 19329827
[TBL] [Abstract][Full Text] [Related]
14. [The new Kidney Disease: Improving Global Outcomes (KDIGO) guideline for the mineral and bone disorder associated with chronic kidney disease (MBD-CKD)].
Drüeke TB
Nephrol Ther; 2010 Jun; 6(3):149-50. PubMed ID: 20188646
[No Abstract] [Full Text] [Related]
15. Recent advances in CKD-MBD research.
Fukagawa M; Akizawa T
Ther Apher Dial; 2011 Jun; 15 Suppl 1():1. PubMed ID: 21595843
[No Abstract] [Full Text] [Related]
16. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.).
Torregrosa JV; Bover J; Cannata Andía J; Lorenzo V; de Francisco AL; Martínez I; Rodríguez Portillo M; Arenas L; González Parra E; Caravaca F; Martín-Malo A; Fernández Giráldez E; Torres A;
Nefrologia; 2011; 31 Suppl 1():3-32. PubMed ID: 21468161
[No Abstract] [Full Text] [Related]
17. [Chronic kidney disease (CKD) and bone. Targets of serum calcium, phosphate, and parathyroid hormone levels and their controls in maintenance dialysis patients].
Akiba T
Clin Calcium; 2009 Apr; 19(4):537-44. PubMed ID: 19329833
[TBL] [Abstract][Full Text] [Related]
18. [Chronic kidney disease (CKD) and bone. CKD-MBD managements and view in the future].
Watanabe M; Suzuki H; Akizawa T
Clin Calcium; 2009 Apr; 19(4):559-65. PubMed ID: 19329836
[TBL] [Abstract][Full Text] [Related]
19. [Chronic kidney disease (CKD) and bone. Management of chronic kidney disease-mineral and bone disorder in peritoneal dialysis patients].
Yaginuma T; Yamamoto H
Clin Calcium; 2009 Apr; 19(4):508-13. PubMed ID: 19329829
[TBL] [Abstract][Full Text] [Related]
20. Consistent control of mineral and bone disorder in incident hemodialysis patients.
Danese MD; Belozeroff V; Smirnakis K; Rothman KJ
Clin J Am Soc Nephrol; 2008 Sep; 3(5):1423-9. PubMed ID: 18596117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
